+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "TCR Therapies"

T-Cell therapy Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Cancer Treatment Centers), By Indication (Lymphoma, Acute Lymphocytic Leukemia and Others), By Therapy Type, By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

T-Cell therapy Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Cancer Treatment Centers), By Indication (Lymphoma, Acute Lymphocytic Leukemia and Others), By Therapy Type, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • June 2023
  • 263 Pages
  • Global
From
Loading Indicator

The TCR Therapies market within the Oncology Drugs sector is a rapidly growing field of research and development. It is based on the use of T-cell receptors (TCRs) to target and destroy cancer cells. TCR Therapies are a form of immunotherapy, which uses the body's own immune system to fight cancer. This type of therapy has been shown to be effective in treating a variety of cancers, including leukemia, lymphoma, and melanoma. TCR Therapies are typically administered through a combination of drugs, such as monoclonal antibodies, cytokines, and other immunomodulators. These drugs are designed to target specific cancer cells and activate the body's immune system to attack them. The goal of TCR Therapies is to provide a more targeted approach to cancer treatment, with fewer side effects than traditional chemotherapy. Some of the companies in the TCR Therapies market include Kite Pharma, Juno Therapeutics, and Bluebird Bio. These companies are focused on developing and commercializing TCR Therapies for the treatment of various types of cancer. Show Less Read more